BriaCell Therapeutics Corp. (BCTX)
3.575
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
3.54
-0.04
(-0.98%)
Pre-Market: 20:00
BriaCell Therapeutics Shareholders Equity (Quarterly) : 24.06M for April 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 24.06M |
| January 31, 2026 | 30.92M |
| October 31, 2025 | 9.978M |
| July 31, 2025 | 17.88M |
| April 30, 2025 | 12.42M |
| January 31, 2025 | 3.603M |
| October 31, 2024 | 4.043M |
| July 31, 2024 | -2.382M |
| April 30, 2024 | -5.965M |
| January 31, 2024 | -8.073M |
| October 31, 2023 | 2.721M |
| July 31, 2023 | -3.777M |
| April 30, 2023 | -5.892M |
| January 31, 2023 | -1.281M |
| October 31, 2022 | 10.33M |
| July 31, 2022 | |
| April 30, 2022 | 45.82M |
| January 31, 2022 | 47.70M |
| October 31, 2021 | 55.39M |
| July 31, 2021 | |
| April 30, 2021 | 13.79M |
| January 31, 2021 | -3.542M |
| October 31, 2020 | -3.367M |
| July 31, 2020 | -3.300M |
| April 30, 2020 | -2.753M |
| Date | Value |
|---|---|
| January 31, 2020 | -2.260M |
| October 31, 2019 | -0.8178M |
| July 31, 2019 | -0.6444M |
| April 30, 2019 | 0.6437M |
| January 31, 2019 | -0.6051M |
| October 31, 2018 | 0.3614M |
| July 31, 2018 | 0.9457M |
| April 30, 2018 | 2.353M |
| January 31, 2018 | 0.4724M |
| October 31, 2017 | 0.9826M |
| July 31, 2017 | 0.7477M |
| April 30, 2017 | 1.574M |
| January 31, 2017 | 1.368M |
| October 31, 2016 | 1.615M |
| July 31, 2016 | 0.7884M |
| April 30, 2016 | 1.138M |
| January 31, 2016 | 0.5186M |
| October 31, 2015 | 0.8727M |
| July 31, 2015 | 1.159M |
| April 30, 2015 | 1.535M |
| January 31, 2015 | 1.657M |
| October 31, 2014 | 0.6055M |
| July 31, 2014 | 0.7529M |
| April 30, 2014 | 8.069M |
| January 31, 2014 | 8.478M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 8.811M |
| ProMIS Neurosciences, Inc. | 49.40M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.07M |
| Total Liabilities (Quarterly) | 3.662M |
| Current Ratio | 7.072 |